Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies

The initial management of rheumatoid arthritis (RA) has a high impact on disease prognosis. Therefore, we need to select the most appropriate treatment as soon as possible. This goal requires biomarkers of disease severity and prognosis. One such biomarker may be the presence of anti-carbamylated pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Regueiro, Cristina, Nuño, Laura, Triguero-Martinez, Ana, Ortiz, Ana M., Villalba, Alejandro, Bóveda, María Dolores, Martínez-Feito, Ana, Conde, Carmen, Balsa, Alejandro, González-Alvaro, Isidoro, Gonzalez, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113595/
https://www.ncbi.nlm.nih.gov/pubmed/33976334
http://dx.doi.org/10.1038/s41598-021-89502-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113595/
https://www.ncbi.nlm.nih.gov/pubmed/33976334
http://dx.doi.org/10.1038/s41598-021-89502-y

Ejemplares similares